RhumbLine Advisers Portfolio holdings
AUM
$117B
This Quarter Return
+5.28%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$39.5B
AUM Growth
+$39.5B
(+8.7%)
Cap. Flow
+$1.87B
Cap. Flow
% of AUM
4.74%
Top 10 Holdings %
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,802
Reduced
995
Closed
66
Top Buys
| 1 |
Intercontinental Exchange
ICE
|
$45.9M |
| 2 |
Exxon Mobil
XOM
|
$26.9M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$23.3M |
| 4 |
Apple
AAPL
|
$21M |
| 5 |
Monster Beverage
MNST
|
$19.9M |
Top Sells
| 1 |
Alcoa
AA
|
$50.1M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
$24.4M |
| 3 |
Procter & Gamble
PG
|
$20.9M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$19.5M |
| 5 |
ITC
ITC HOLDINGS CORP
ITC
|
$9.25M |
Sector Composition
| 1 | Financials | 16.57% |
| 2 | Technology | 14.49% |
| 3 | Healthcare | 12.77% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MN
2801
DELISTED
MANNING & NAPIER, INC.
MN
| $86K | ﹤0.01% |
11,412
-2,571
| -18% | -$19.4K |
|
|
RLH
2802
DELISTED
Red Lions Hotel Corporation
RLH
| $86K | ﹤0.01% |
+10,291
| New | +$86K |
|
2803
Arrowhead Research
ARWR
$3.44B
| $84K | ﹤0.01% |
54,398
-8,315
| -13% | -$12.8K |
|
|
PMBC
2804
DELISTED
Pacific Mercantile Bancorp
PMBC
| $83K | ﹤0.01% |
+11,363
| New | +$83K |
|
2805
Talphera
TLPH
$11.2M
| $82K | ﹤0.01% |
31,567
-7,880
| -20% | -$20.5K |
|
2806
Genie Energy
GNE
$406M
| $76K | ﹤0.01% |
13,184
-2,296
| -15% | -$13.2K |
|
|
NEOS
2807
DELISTED
Neos Therapeutics, Inc
NEOS
| $76K | ﹤0.01% |
12,983
+2,878
| +28% | +$16.8K |
|
|
NAGE
2808
Niagen Bioscience, Inc. Common Stock
NAGE
$774M
| $74K | ﹤0.01% |
22,314
-17,087
| -43% | -$56.7K |
|
|
ASXC
2809
DELISTED
Asensus Surgical, Inc.
ASXC
| $74K | ﹤0.01% |
56,775
-1,359
| -2% | -$1.77K |
|
2810
Fortress Biotech
FBIO
$88.7M
| $73K | ﹤0.01% |
27,039
+3,011
| +13% | +$8.13K |
|
2811
Vince Holding
VNCE
$18.2M
| $70K | ﹤0.01% |
17,348
-1,192
| -6% | -$4.81K |
|
2812
Larimar Therapeutics
LRMR
$325M
| $68K | ﹤0.01% |
21,283
-13,709
| -39% | -$43.8K |
|
2813
Valhi
VHI
$444M
| $67K | ﹤0.01% |
19,439
-1,475
| -7% | -$5.08K |
|
|
IMDZ
2814
DELISTED
Immune Design Corp.
IMDZ
| $67K | ﹤0.01% |
12,151
+1,652
| +16% | +$9.11K |
|
|
AST
2815
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $65K | ﹤0.01% |
14,050
+1,786
| +15% | +$8.26K |
|
|
INFI
2816
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $64K | ﹤0.01% |
47,625
-34,964
| -42% | -$47K |
|
|
ALJJ
2817
DELISTED
ALJ Regional Holdings, Inc. Common Stock
ALJJ
| $63K | ﹤0.01% |
14,351
-9,443
| -40% | -$41.5K |
|
2818
Titan Pharmaceuticals
TTNP
$4.84M
| $60K | ﹤0.01% |
14,879
+1,300
| +10% | +$5.24K |
|
2819
Adverum Biotechnologies
ADVM
$62.3M
| $58K | ﹤0.01% |
19,833
-4,939
| -20% | -$14.4K |
|
2820
Senseonics Holdings
SENS
$364M
| $58K | ﹤0.01% |
21,881
+2,501
| +13% | +$6.63K |
|
|
TTOO
2821
DELISTED
T2 Biosystems, Inc
TTOO
| $55K | ﹤0.01% |
10,480
-425
| -4% | -$2.23K |
|
|
MRTX
2822
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $55K | ﹤0.01% |
11,629
-1,458
| -11% | -$6.9K |
|
2823
Tempest Therapeutics
TPST
$44.4M
| $53K | ﹤0.01% |
34,884
-9,616
| -22% | -$14.6K |
|
2824
Cardiff Oncology
CRDF
$131M
| $52K | ﹤0.01% |
24,915
-14,926
| -37% | -$31.2K |
|
2825
CPI Card Group
PMTS
$171M
| $52K | ﹤0.01% |
12,439
-2,186
| -15% | -$9.14K |
|